| [1] | Wang H, Zhang H, Zou ZY. Changing profiles of cardiovascular disease and risk factors in China: a secondary analysis for the Global Burden of Disease Study 2019. Chin Med J, 2023; 136, 2431−41. doi: 10.1097/CM9.0000000000002741 |
| [2] | Wang W, Liu YN, Liu JM, et al. Mortality and years of life lost of cardiovascular diseases in China, 2005-2020: empirical evidence from national mortality surveillance system. Int J Cardiol, 2021; 340, 105−12. doi: 10.1016/j.ijcard.2021.08.034 |
| [3] | National Health Commission. China health statistics yearbook 2022. Peking Union Medical College Press. 2022. (In Chinese) |
| [4] | Li YC, Liu SW, Zeng XY, et al. Report on burden of cardiovascular diseases from 1990 to 2016 in China. Chin Circ J, 2019; 34, 729−40. (In Chinese) |
| [5] | Liu SW, Li YC, Zeng XY, et al. Burden of cardiovascular diseases in China, 1990-2016: findings from the 2016 Global Burden of Disease Study. JAMA Cardiol, 2019; 4, 342−52. doi: 10.1001/jamacardio.2019.0295 |
| [6] | Ma QF, Li R, Wang LJ, et al. Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health, 2021; 6, e897−906. doi: 10.1016/S2468-2667(21)00228-0 |
| [7] | Sun T, Chen SY, Wu K, et al. Trends in incidence and mortality of stroke in China from 1990 to 2019. Front Neurol, 2021; 12, 759221. doi: 10.3389/fneur.2021.759221 |
| [8] | GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet, 2021; 397, 2337−60. doi: 10.1016/S0140-6736(21)01169-7 |
| [9] | Liu Z, Li YH, Cui ZY, et al. Prevalence of tobacco dependence and associated factors in China: findings from nationwide China Health Literacy Survey during 2018-19. Lancet Reg Health West Pac, 2022; 24, 100464. |
| [10] | Chan KH, Wright N, Xiao D, et al. Tobacco smoking and risks of more than 470 diseases in China: a prospective cohort study. Lancet Public Health, 2022; 7, e1014−26. doi: 10.1016/S2468-2667(22)00227-4 |
| [11] | Zheng YT, Wu YQ, Wang MY, et al. Impact of a comprehensive tobacco control policy package on acute myocardial infarction and stroke hospital admissions in Beijing, China: interrupted time series study. Tob Control, 2021; 30, 434−42. doi: 10.1136/tobaccocontrol-2020-055663 |
| [12] | Wu YQ, Wang ZJ, Zheng YT, et al. Trends in hospital admissions for chronic obstructive pulmonary diseases after comprehensive tobacco control policies in Beijing, China. Nicotine Tob Res, 2022; 24, 1978−84. doi: 10.1093/ntr/ntac137 |
| [13] | Shi YL, Xiong JF, Liu LQ, et al. Impact of smoke-free legislation on acute myocardial infarction and subtypes of stroke incidence in Shenzhen, China, 2012-2016: an Interrupted time series analysis. Biomed Environ Sci, 2023; 36, 527−36. |
| [14] | National Disease Control and Prevention Administration. Report on nutrition and chronic diseases of Chinese residents (2020). People’s Medical Publishing House. 2021. (In Chinese) |
| [15] | Zhao LY, Ding GQ, Zhao WH. Surveillance report on nutrition and health status of Chinese residents from 2015 to 2017. People’s Medical Publishing House. 2022. (In Chinese) |
| [16] | Huang K, Fang HY, Yu DM, et al. Usual intake of micronutrients and prevalence of inadequate intake among Chinese adults: data from CNHS 2015-2017. Nutrients, 2022; 14, 4714. doi: 10.3390/nu14224714 |
| [17] | Fang YH, Xia J, Lian YY, et al. The burden of cardiovascular disease attributable to dietary risk factors in the provinces of China, 2002-2018: a nationwide population-based study. Lancet Reg Health West Pac, 2023; 37, 100784. |
| [18] | Liu CY, Wang LM, Gao XX, et al. Intake of vegetables and fruit among adults in China in 2018. Chin J Prev Control Chronic Dise, 2022; 30, 561−6. (In Chinese) |
| [19] | Zhang ST, Wang LS, Jia XF, et al. A comparison between dietary consumption status and healthy dietary pattern among adults aged 55 and older in China. Nutrients, 2022; 14, 2778. doi: 10.3390/nu14132778 |
| [20] | Ju LH, Zhao LY, Fang HY, et al. Main food intakes of Chinese children aged 6 – 17 years, 2016 – 2017: surveillance data-based evaluation. Chin J Public Health, 2023; 39, 550−5. (In Chinese) |
| [21] | Xu Y, Gan Q, Zhang Q, et al. Association of beverages intake with myopia among 11-14-year-old Chinese children in 2019-2021. J Hyg Res, 2023; 51, 707−12,719. (In Chinese) |
| [22] | Zhu JF, Gu JC, Yang MQ, et al. Ischemic heart disease burden attributable to high-salt diet and the trend change from 1990 to 2019 in China. Chin Circ J, 2023; 38, 337−42. (In Chinese) |
| [23] | Xu Y, Li ZX, Ma Y, et al. Disease burden of type 2 diabetes mellitus attributable to dietary factors in Chinese residents aged 15 and above from 1990 to 2019. Chin Circ J, 2022; 37, 1016−22. (In Chinese) |
| [24] | Li L, Yang HY, Ma Y, et al. Whole fresh fruit intake and risk of incident diabetes in different glycemic stages: a nationwide prospective cohort investigation. Eur J Nutr, 2023; 62, 771−782. |
| [25] | Li M, Shi ZM. Association between ultra-processed food consumption and diabetes in Chinese Adults-results from the China Health and Nutrition Survey. Nutrients, 2022; 14, 4241. doi: 10.3390/nu14204241 |
| [26] | Li M, Shi ZM. Ultra-processed food consumption associated with incident hypertension among Chinese adults-results from China Health and Nutrition Survey 1997-2015. Nutrients, 2022; 14, 4783. doi: 10.3390/nu14224783 |
| [27] | Zhao LG, Li HL, Liu DK, et al. Dietary glycemic index, glycemic load, and cause-specific mortality: two population-based prospective cohort studies. Eur J Clin Nutr, 2022; 76, 1142−9. doi: 10.1038/s41430-022-01083-9 |
| [28] | Yang YX, Yu DM, Piao W, et al. Nutrient-derived beneficial for blood pressure dietary pattern associated with hypertension prevention and control: based on China Nutrition and Health Surveillance 2015-2017. Nutrients, 2022; 14, 3108. doi: 10.3390/nu14153108 |
| [29] | Chinese Center for Disease Control and Prevention, Chronic Non communicable Disease Prevention and Control Center of China Center for Disease Control and Prevention. Report on chronic disease risk factor surveillance in China 2018. People's Health Publishing House. 2021. (In Chinese) |
| [30] | Li C, Wang LM, Zhang X, et al. Leisure-time physical activity among Chinese adults — China, 2015. China CDC Wkly, 2020; 2, 671−7. |
| [31] | Song Y, Luo DM, Hu PJ, et al. Trends of prevalence of excellent health status and physical fitness among Chinese Han students aged 13 to 18 years from 1985 to 2014. J Peking Univ (Health Sci), 2020; 52, 317−22. (In Chinese) |
| [32] | Yang X, Leung AW, Jago R, et al. Physical activity and sedentary behaviors among Chinese children: recent trends and correlates. Biomed Environ Sci, 2021; 34, 425−38. |
| [33] | Chen PJ. Report on physical activity and fitness in China the youth study (2016). Science Press. 2018. (In Chinese) |
| [34] | Cai YJ, Zhu XH, Wu XP. Physical activity among Chinese school-aged children: national prevalence estimates from the 2016 Physical Activity and Fitness in China-The Youth Study. J Sport Health Sci, 2017; 6, 404−9. doi: 10.1016/j.jshs.2017.09.002 |
| [35] | Zhu Z, Tang Y, Zhuang J, et al. Physical activity, screen viewing time, and overweight/obesity among Chinese children and adolescents: an update from the 2017 physical activity and fitness in China-the youth study. BMC Public Health, 2019; 19, 197. doi: 10.1186/s12889-019-6515-9 |
| [36] | Xin F, Zhu Z, Chen ST, et al. Prevalence and correlates of meeting the muscle-strengthening exercise recommendations among Chinese children and adolescents: results from 2019 physical activity and fitness in China-the youth study. J Sport Health Sci, 2022; 11, 358−66. doi: 10.1016/j.jshs.2021.09.010 |
| [37] | Strain T, Brage S, Sharp SJ, et al. Use of the prevented fraction for the population to determine deaths averted by existing prevalence of physical activity: a descriptive study. Lancet Glob Health, 2020; 8, e920−30. doi: 10.1016/S2214-109X(20)30211-4 |
| [38] | Bennett DA, Du HD, Clarke R, et al. Association of physical activity with risk of major cardiovascular diseases in Chinese men and women. JAMA Cardiol, 2017; 2, 1349−58. doi: 10.1001/jamacardio.2017.4069 |
| [39] | Fan MY, Lv J, Yu CQ, et al. Association between active commuting and incident cardiovascular diseases in Chinese: a prospective cohort study. J Am Heart Assoc, 2019; 8, e012556. doi: 10.1161/JAHA.119.012556 |
| [40] | Liu Q, Liu FC, Huang KY, et al. Beneficial effects of moderate to vigorous physical activity on cardiovascular disease among Chinese adults. J Geriatr Cardiol, 2020; 17, 85−95. |
| [41] | Hu P, Zheng MR, Huang J, et al. Association of habitual physical activity with the risk of all-cause mortality among Chinese adults: a prospective cohort study. Frontiers Public Health, 2022; 10, 919306. doi: 10.3389/fpubh.2022.919306 |
| [42] | Wang YH, Liu Y, Hu JJ, et al. Association of handgrip strength with all-cause mortality: a nationally longitudinal cohort study in China. J Sci Med Sport, 2022; 25, 878−83. doi: 10.1016/j.jsams.2022.08.005 |
| [43] | Dong YH, Chen L, Liu JY, et al. Epidemiology and prediction of overweight and obesity among children and adolescents aged 7-18 years in China from 1985 to 2019. Chin J Prev Med, 2023; 57, 461−9. (In Chinese) |
| [44] | Yang YP, Song LL, Wang LL, et al. Effect of body mass index trajectory on lifetime risk of cardiovascular disease in a Chinese population: a cohort study. Nutr Metab Cardiovasc Dis, 2023; 33, 523−31. doi: 10.1016/j.numecd.2022.11.025 |
| [45] | Global Burden Disease 2019. Global health data exchange. (2022-08-27)[2024-07-06]. |
| [46] | Tian X, Chen SH, Wang PL, et al. Insulin resistance mediates obesity-related risk of cardiovascular disease: a prospective cohort study. Cardiovasc Diabetol, 2022; 21, 289. doi: 10.1186/s12933-022-01729-9 |
| [47] | Zhang M, Wu J, Zhang X, et al. Prevalence and control of hypertension in adults in China, 2018. Chin J Epidemiol, 2021; 42, 1780−9. (In Chinese) |
| [48] | Chen L, Zhang Y, Ma T, et al. Prevalence trend of high normal blood pressure and elevated blood pressure in Chinese Han children and adolescents aged 7-17 years from 2010 to 2019. Chin J Prev Med, 2023; 57, 499−507. (In Chinese) |
| [49] | Luo YM, Xia F, Yu XX, et al. Long-term trends and regional variations of hypertension incidence in China: a prospective cohort study from the China Health and Nutrition Survey, 1991-2015. BMJ Open, 2021; 11, e042053. doi: 10.1136/bmjopen-2020-042053 |
| [50] | Zhang M, Shi Y, Zhou B, et al. Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey. BMJ, 2023; 380, e071952. |
| [51] | Yi Q, Zha MM, Yang QW, et al. Trends in the prevalence of hypertension according to severity and phenotype in Chinese adults over two decades (1991-2015). J Clin Hypertens (Greenwich), 2021; 23, 1302−15. doi: 10.1111/jch.14306 |
| [52] | Wang ZW, Chen Z, Zhang LF, et al. Status of hypertension in China: results from the China Hypertension Survey, 2012-2015. Circulation, 2018; 137, 2344−56. doi: 10.1161/CIRCULATIONAHA.117.032380 |
| [53] | Yuan YF, Jin AM, Neal B, et al. Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial. Nat Med, 2023; 29, 973−81. doi: 10.1038/s41591-023-02286-8 |
| [54] | Zhou MG, Wang HD, Zeng XY, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2019; 394, 1145−58. doi: 10.1016/S0140-6736(19)30427-1 |
| [55] | Cao X, Zhao ZP, Kang YT, et al. The burden of cardiovascular disease attributable to high systolic blood pressure across China, 2005-18: a population-based study. Lancet Public Health, 2022; 7, e1027−40. doi: 10.1016/S2468-2667(22)00232-8 |
| [56] | Zhao WH, Zhang J, You Y, et al. Epidemiologic characteristics of dyslipidemia in people aged 18 years and over in China. Chin J Prev Med, 2005; 39, 306−10. (In Chinese) |
| [57] | Pan L, Yang ZH, Wu Y, et al. The prevalence, awareness, treatment and control of dyslipidemia among adults in China. Atherosclerosis, 2016; 248, 2−9. doi: 10.1016/j.atherosclerosis.2016.02.006 |
| [58] | Dai J, Min JQ, Yang YJ. A study on the epidemic characteristics of dyslipidemia in adults of nine provinces of China. Chin J Cardiol, 2018; 46, 114−8. (In Chinese) |
| [59] | National Health and Family Planning Commission. Report on the status of nutrition and chronic diseases among Chinese residents (2015). People’s Health Publishing House. 2015. (In Chinese) |
| [60] | Li SN, Zhang LF, Wang X, et al. Status of dyslipidemia among adults aged 35 years and above in China. Chin Circ J, 2019; 34, 681−7. (In Chinese) |
| [61] | Lu Y, Zhang HB, Lu JP, et al. Prevalence of dyslipidemia and availability of lipid-lowering medications among primary health care settings in China. JAMA Network Open, 2021; 4, e2127573. doi: 10.1001/jamanetworkopen.2021.27573 |
| [62] | Zhang M, Deng Q, Wang LH, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163, 641 adults. Int J Cardiol, 2018; 260, 196−203. doi: 10.1016/j.ijcard.2017.12.069 |
| [63] | Song PK, Man QQ, Li H, et al. Trends in lipids level and dyslipidemia among Chinese adults, 2002-2015. Biomed Environ Sci, 2019; 32, 559−70. |
| [64] | Opoku S, Gan Y, Fu WN, et al. Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP). BMC Public Health, 2019; 19, 1500. doi: 10.1186/s12889-019-7827-5 |
| [65] | NCD Risk Factor Collaboration (NCD-RisC). Repositioning of the global epicentre of non-optimal cholesterol. Nature, 2020; 582, 73−7. doi: 10.1038/s41586-020-2338-1 |
| [66] | Xu XH, Yang J, Wang LJ, et al. Burden of disease attributed to high level serum low-density lipoprotein cholesterol in China in 2017. Chin J Epidemiol, 2020; 41, 839−44. (In Chinese) |
| [67] | Dai HJ, Much AA, Maor E, et al. Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990-2017: results from the Global Burden of Disease Study 2017. Eur Heart J- Qual Care Clin Outcomes, 2022; 8, 50−60. doi: 10.1093/ehjqcco/qcaa076 |
| [68] | GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol, 2021; 20, 795−820. doi: 10.1016/S1474-4422(21)00252-0 |
| [69] | Li JH, Wang LM, Zhang M, et al. Awareness rate, treatment rate and control rate of dyslipidemia in Chinese adults, 2010. Chin J Prev Med, 2012; 46, 687−91. (In Chinese) |
| [70] | Yang WY, Xiao JZ, Yang ZJ, et al. Serum lipids and lipoproteins in Chinese men and women. Circulation, 2012; 125, 2212−21. doi: 10.1161/CIRCULATIONAHA.111.065904 |
| [71] | Teng HB, Gao Y, Wu CQ, et al. Prevalence and patient characteristics of familial hypercholesterolemia in a Chinese population aged 35-75 years: results from China PEACE Million Persons Project. Atherosclerosis, 2022; 350, 58−64. doi: 10.1016/j.atherosclerosis.2022.03.027 |
| [72] | Xing YY, Liu J, Hao YC, et al. Prehospital statin use and low-density lipoprotein cholesterol levels at admission in acute coronary syndrome patients with history of myocardial infarction or revascularization: findings from the Improving Care for Cardiovascular Disease in China (CCC) project. Am Heart J, 2019; 212, 120−8. doi: 10.1016/j.ahj.2019.02.019 |
| [73] | Xing YY, Liu J, Liu J, et al. Statin use and low-density lipoprotein cholesterol levels in patients aged 75 years and older with acute coronary syndrome in China. Chin J Cardiol, 2019; 47, 351−9. (In Chinese) |
| [74] | Gong YJ, Li X, Ma X, et al. Lipid goal attainment in post-acute coronary syndrome patients in China: results from the 6-month real-world dyslipidemia international study II. Clin Cardiol, 2021; 44, 1575−85. doi: 10.1002/clc.23725 |
| [75] | Bi L, Yi JY, Wu CQ, et al. Atherosclerotic cardiovascular disease risk and lipid-lowering therapy requirement in China. Front Cardiovasc Med, 2022; 9, 839571. doi: 10.3389/fcvm.2022.839571 |
| [76] | Li YZ, Teng D, Shi XG, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ, 2020; 369, m997. |
| [77] | Yang C, Wang HB, Zhao XJ, et al. CKD in China: evolving spectrum and public health implications. Am J Kidney Dis, 2020; 76, 258−64. doi: 10.1053/j.ajkd.2019.05.032 |
| [78] | Wang LM, Xu X, Zhang M, et al. Prevalence of chronic kidney disease in China: results from the Sixth China Chronic Disease and Risk Factor Surveillance. JAMA Intern Med, 2023; 183, 298−310. doi: 10.1001/jamainternmed.2022.6817 |
| [79] | Zhang LX, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet, 2012; 379, 815−22. doi: 10.1016/S0140-6736(12)60033-6 |
| [80] | Zhang LX, Zhao MH, Zuo L, et al. China Kidney Disease Network (CK-NET) 2016 Annual Data Report. Kidney Int Suppl (2011), 2020; 10, e97−185. doi: 10.1016/j.kisu.2020.09.001 |
| [81] | Wang J, Wu JX, Liu JM, et al. Prevalence of sleep disturbances and associated factors among Chinese residents: a web-based empirical survey of 2019. J Glob Health, 2023; 13, 04071. doi: 10.7189/jogh.13.04071 |
| [82] | Li L, Li L, Chai JX, et al. Prevalence of poor sleep quality in patients with hypertension in China: a meta-analysis of comparative studies and epidemiological surveys. Front Psychiatry, 2020; 11, 591. |
| [83] | Huang YQ, Wang Y, Wang H, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry, 2019; 6, 211−24. doi: 10.1016/S2215-0366(18)30511-X |
| [84] | Jia ZX, Du X, Du J, et al. Prevalence and factors associated with depressive and anxiety symptoms in a Chinese population with and without cardiovascular diseases. J Affect Disord, 2021; 286, 241−7. doi: 10.1016/j.jad.2021.02.006 |
| [85] | Wu M, Zhu YQ, Lv J, et al. Association of anxiety with cardiovascular disease in a Chinese cohort of 0.5 million adults. J Affect Disord, 2022; 315, 291−6. doi: 10.1016/j.jad.2022.08.008 |
| [86] | Fang W, Li ZX, Gao JH, et al. The joint and interaction effect of high temperature and humidity on mortality in China. Environ Int, 2023; 171, 107669. doi: 10.1016/j.envint.2022.107669 |
| [87] | Yin P, Chen RJ, Wang LJ, et al. The added effects of heatwaves on cause-specific mortality: a nationwide analysis in 272 Chinese cities. Environ Int, 2018; 121, 898−905. doi: 10.1016/j.envint.2018.10.016 |
| [88] | Chen RJ, Yin P, Wang LJ, et al. Association between ambient temperature and mortality risk and burden: time series study in 272 main Chinese cities. BMJ, 2018; 363, k4306. |
| [89] | Yang J, Yin P, Zhou MG, et al. Cardiovascular mortality risk attributable to ambient temperature in China. Heart, 2015; 101, 1966−72. doi: 10.1136/heartjnl-2015-308062 |
| [90] | Ministry of Ecology and Environment of the People’s Republic of China. 2021 Report on the state of the ecology and environment. (2022-05-26)[2024-05-26]. (In Chinese) |
| [91] | Yu K, Lv J, Qiu GK, et al. Cooking fuels and risk of all-cause and cardiopulmonary mortality in urban China: a prospective cohort study. Lancet Glob Health, 2020; 8, e430−9. doi: 10.1016/S2214-109X(19)30525-X |
| [92] | Qiu SY, Chen XF, Chen XF, et al. Solid fuel use, socioeconomic indicators and risk of cardiovascular diseases and all-cause mortality: a prospective cohort study in a rural area of Sichuan, China. Int J Epidemiol, 2022; 51, 501−13. doi: 10.1093/ije/dyab191 |
| [93] | Meng WJ, Shen GF, Shen HZ, et al. Synergistic health benefits of household stove upgrading and energy switching in rural China. Environ Sci Technol, 2021; 55, 14567−75. doi: 10.1021/acs.est.1c04242 |
| [94] | Cao X, Tang HS, Zheng CY, et al. Association of heating fuel types with mortality and cardiovascular events among non-smokers in China. Environ Pollut, 2021; 291, 118207. doi: 10.1016/j.envpol.2021.118207 |
| [95] | National Center for Cardiovascular Quality Improvement. Report on the national medical service and quality safety in 2023. China Union Medical College Press. 2024. (In Chinese) |
| [96] | Zhang DW, Gu DC, Rao CF, et al. Outcome differences between surgeons performing first and subsequent coronary artery bypass grafting procedures in a day: a retrospective comparative cohort study. BMJ Qual Saf, 2023; 32, 192−201. doi: 10.1136/bmjqs-2021-014244 |
| [97] | Dong XJ, Ding F, Zhou SD, et al. Optimizing an emergency medical dispatch system to improve prehospital diagnosis and treatment of acute coronary syndrome: nationwide retrospective study in China. J Med Internet Res, 2022; 24, e36929. doi: 10.2196/36929 |
| [98] | Cai AP, Qiu WD, Zhou YL, et al. Clinical characteristics and 1-year outcomes in hospitalized patients with heart failure with preserved ejection fraction: results from the China cardiovascular association database-heart failure center registry. Eur J Heart Fail, 2022; 24, 2048−62. doi: 10.1002/ejhf.2654 |
| [99] | Zhang YH, Gao CY, Greene SJ, et al. Clinical performance and quality measures for heart failure management in China: the China-heart failure registry study. ESC Heart Fail, 2023; 10, 342−52. doi: 10.1002/ehf2.14184 |
| [100] | Chinese Society of Biomedical Engineering Extracorporeal Circulation Branch. White book of Chinese cardiovascular surgery and extracorporeal circulation in 2022. Chin J Extracorpor Circ, 2023; 21, 197−200. (In Chinese) |
| [101] | Lin HY, Chang Y, Zhou HY, et al. Early results of frozen elephant trunk in acute type-A dissection in 1445 patients. Int J Cardiol, 2023; 389, 131213. doi: 10.1016/j.ijcard.2023.131213 |
| [102] | Zhao R, Qiu JT, Dai L, et al. Current surgical management of acute type A aortic dissection in China: a multicenter registry study. JACC: Asia, 2022; 2, 869−78. doi: 10.1016/j.jacasi.2022.08.009 |
| [103] | Qin YL, Wang F, Li TX, et al. Endovascular repair compared with medical management of patients with uncomplicated type B acute aortic dissection. J Am Coll Cardiol, 2016; 67, 2835−42. doi: 10.1016/j.jacc.2016.03.578 |
| [104] | Zhou YP, Wei YP, Yang YJ, et al. Percutaneous pulmonary angioplasty for patients with Takayasu arteritis and pulmonary hypertension. J Am Coll Cardiol, 2022; 79, 1477−88. |
| [105] | Zhang SS, Ding RJ, Chen SK, et al. Availability and trend of dissemination of cardiac rehabilitation in China: report from the multicenter national registration platform between 2012 and 2021. Front Cardiovasc Med, 2023; 10, 1210068. doi: 10.3389/fcvm.2023.1210068 |
| [106] | National Center for Cardiovascular Diseases. Report on cardiovascular health and diseases in China 2023: an updated summary. Peking Union Medical College Press. 2024. (In Chinese) |